ATE90202T1 - Wirkstoffabgabevorrichtung. - Google Patents

Wirkstoffabgabevorrichtung.

Info

Publication number
ATE90202T1
ATE90202T1 AT90301617T AT90301617T ATE90202T1 AT E90202 T1 ATE90202 T1 AT E90202T1 AT 90301617 T AT90301617 T AT 90301617T AT 90301617 T AT90301617 T AT 90301617T AT E90202 T1 ATE90202 T1 AT E90202T1
Authority
AT
Austria
Prior art keywords
delivery device
piece
female piece
agents delivery
devices
Prior art date
Application number
AT90301617T
Other languages
English (en)
Inventor
Marion Eileen Mcneill
Abdul Rashid
Howard Norman Ernest Stevens
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898903566A external-priority patent/GB8903566D0/en
Priority claimed from GB898921155A external-priority patent/GB8921155D0/en
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE90202T1 publication Critical patent/ATE90202T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Surgical Instruments (AREA)
  • Massaging Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Molding Of Porous Articles (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Eye Examination Apparatus (AREA)
AT90301617T 1989-02-16 1990-02-15 Wirkstoffabgabevorrichtung. ATE90202T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898903566A GB8903566D0 (en) 1989-02-16 1989-02-16 Drug dispensing device
GB898921155A GB8921155D0 (en) 1989-09-19 1989-09-19 Drug dispensing device

Publications (1)

Publication Number Publication Date
ATE90202T1 true ATE90202T1 (de) 1993-06-15

Family

ID=26294964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90301617T ATE90202T1 (de) 1989-02-16 1990-02-15 Wirkstoffabgabevorrichtung.

Country Status (18)

Country Link
EP (2) EP0384646B1 (de)
JP (1) JPH0818971B2 (de)
KR (1) KR0141473B1 (de)
AT (1) ATE90202T1 (de)
AU (1) AU629915B2 (de)
CA (1) CA2047738C (de)
DE (1) DE69001831T2 (de)
DK (1) DK0384646T3 (de)
ES (1) ES2043270T3 (de)
FI (1) FI913880A7 (de)
GB (1) GB2230442B (de)
HU (1) HU207940B (de)
IE (1) IE64761B1 (de)
NO (1) NO303618B1 (de)
NZ (1) NZ232561A (de)
PT (1) PT93170B (de)
RU (1) RU2104084C1 (de)
WO (1) WO1990009168A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5474784A (en) * 1990-03-02 1995-12-12 British Technology Group Limited Dispensing device
GB9004702D0 (en) * 1990-03-02 1990-04-25 Polysystems Limited Dispensing device
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
AU652984B2 (en) * 1992-01-14 1994-09-15 Endo Pharmaceuticals Solutions Inc. Preparation of homogeneous hydrogel copolymers
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
GB9223146D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Vented capsule
GB9223148D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule cap
SK104895A3 (en) * 1993-02-26 1996-06-05 Procter & Gamble Pharmaceutical composition and its use
WO1994023705A1 (en) * 1993-04-20 1994-10-27 Tsrl, Inc. Multi-stage drug delivery system
GB9320733D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled release device construction
GB9320732D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled delivery of liquid
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
GB9323261D0 (en) * 1993-11-11 1994-01-05 Scherer Corp R P Dispensing device
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
NZ283160A (en) 1994-05-06 1998-07-28 Pfizer Azithromycin in a controlled release dosage form for treating microbiol infections
GB9718664D0 (en) 1997-09-04 1997-11-05 Scherer Corp R P Improvements in or relating to capsules
GB9724450D0 (en) * 1997-11-20 1998-01-14 Scherer Corp R P Delayed release device
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
CA2320193A1 (en) 1998-02-10 1999-08-19 Welfide Corporation Controlled release preparation
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
CA2570960C (en) 2004-06-17 2013-10-01 Valera Pharmaceuticals, Inc. Compositions and methods for treating central precocious puberty
EP1888043A4 (de) 2005-03-11 2010-07-28 Endo Pharmaceuticals Solutions Octreotid-formulierungen mit kontrollierter freisetzung
PL1916995T5 (pl) 2005-07-29 2022-10-31 Stichting Groningen Centre For Drug Research Kontrolowany wartością ph impulsowy układ podawczy, sposoby przygotowania i zastosowanie
CN101583620B (zh) 2005-11-28 2016-08-17 马里纳斯医药公司 加奈索酮组合物及其制备和使用方法
EP2364701A1 (de) 2005-12-20 2011-09-14 Cenestra, Llc Zubereitung enthaltend Omega 3 Fettsäuren
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
US20100105738A1 (en) 2006-10-06 2010-04-29 Mitsuru Mizuno Extended release formulations of a proton pump inhibitor
MX2009011641A (es) 2007-04-27 2010-03-04 Endo Pharmaceuticals Solutions Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.
JP5536053B2 (ja) 2008-06-25 2014-07-02 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド． 離型剤を有するオクトレオチドインプラント
US8071537B2 (en) 2008-06-25 2011-12-06 Endo Pharmaceuticals Solutions Inc. Implantable device for the sustained release of a polypeptide
JP5698683B2 (ja) 2009-03-09 2015-04-08 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 治療薬のパルス放出組成物
US20170079962A1 (en) 2009-11-11 2017-03-23 Rapamycin Holdings, Llc Oral Rapamycin Preparation and Use for Stomatitus
US9731025B2 (en) 2010-08-20 2017-08-15 National University Corporation Tokyo Medical And Dental University Pharmaceutical composition for transcolonic absorption
MX2021000431A (es) 2011-03-23 2022-10-28 Ironshore Pharmaceuticals & Dev Inc Metodos y composiciones para el tratamiento de trastorno por deficit de atencion.
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
HUE049186T2 (hu) * 2011-08-01 2020-09-28 Hb Biotechnologies Corp Emészthetetlen kapszulák folyadékabszorbeáló anyagok szállításához
MX2014008284A (es) * 2012-01-04 2015-03-03 Wellesley Pharmaceutical Llc Formulacion de liberacion retardada para reducir la frecuencia de orinar y metodos de uso de esta.
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
IN2014DN08449A (de) 2012-03-30 2015-05-08 Sancilio & Company Inc
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
DK3089737T3 (da) 2013-12-31 2021-12-13 Rapamycin Holdings Llc Orale rapamycin-nanopartikelpræparater og anvendelse.
KR20240039186A (ko) 2015-06-03 2024-03-26 트리아스텍 인코포레이티드 제형 및 이의 용도
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
KR20190107712A (ko) 2017-01-26 2019-09-20 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
WO2019137200A1 (en) 2018-01-09 2019-07-18 Triastek, Inc. Oral drug dosage forms comprising a fixed-dose of an adhd non-stimulant and an adhd stimulant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
GB2112370B (en) * 1981-09-04 1984-09-26 Ciba Geigy Ag Inhibition of scale formation and corrosion in aqueous systems
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills

Also Published As

Publication number Publication date
IE900556L (en) 1990-08-16
EP0458887A1 (de) 1991-12-04
JPH04505004A (ja) 1992-09-03
NO913081D0 (no) 1991-08-08
HUT58509A (en) 1992-03-30
PT93170B (pt) 1996-12-31
FI913880A0 (fi) 1991-08-16
GB2230442B (en) 1992-11-25
WO1990009168A1 (en) 1990-08-23
AU629915B2 (en) 1992-10-15
NZ232561A (en) 1992-02-25
ES2043270T3 (es) 1993-12-16
EP0384646B1 (de) 1993-06-09
NO303618B1 (no) 1998-08-10
HU902238D0 (en) 1991-11-28
DE69001831D1 (de) 1993-07-15
HU207940B (en) 1993-07-28
JPH0818971B2 (ja) 1996-02-28
PT93170A (pt) 1990-08-31
GB9003503D0 (en) 1990-04-11
DE69001831T2 (de) 1993-09-16
KR920700617A (ko) 1992-08-10
AU5163290A (en) 1990-09-05
RU2104084C1 (ru) 1998-02-10
NO913081L (no) 1991-08-08
CA2047738C (en) 2000-02-15
CA2047738A1 (en) 1990-08-17
KR0141473B1 (en) 1998-06-01
FI913880A7 (fi) 1991-08-16
DK0384646T3 (da) 1993-07-12
GB2230442A (en) 1990-10-24
IE64761B1 (en) 1995-09-06
EP0384646A1 (de) 1990-08-29

Similar Documents

Publication Publication Date Title
ATE90202T1 (de) Wirkstoffabgabevorrichtung.
DE69612481D1 (de) Mit bändern versehene dosisform zur verlängerten freisetzung eines wirkstoffs
ES2010648A4 (es) Formulaciones farmaceuticas de sustancias labiles frente a los acidospara uso oral.
EP0868912A3 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
AU7992987A (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch
ES2049414T3 (es) Dispositivo de administracion.
GT198303076A (es) Formulaciones de pastillas de accion prolongada con disolucion paulatina.
NO163356C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.
ATE124255T1 (de) Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen.
FR2640547B1 (fr) Materiau composite apte a gonfler en presence d'eau, supports utilisables pour sa fabrication et ses utilisations
SE8803822D0 (sv) Novel dosage form
IT1229502B (it) Composizioni contenenti bismuto idonee per uso terapeutico.
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
AR006565A1 (es) Suspensiones acuosas de beta-ciflutrina
JPS577412A (en) Plaster

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee